financetom
Business
financetom
/
Business
/
Amdocs Fiscal Q4 Non-GAAP EPS, Revenue Increase; Fiscal Q1 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amdocs Fiscal Q4 Non-GAAP EPS, Revenue Increase; Fiscal Q1 Outlook Set
Nov 12, 2024 2:08 PM

04:30 PM EST, 11/12/2024 (MT Newswires) -- Amdocs ( DOX ) reported fiscal Q4 non-GAAP earnings late Tuesday of $1.70 per diluted share, up from $1.42 a year earlier.

Analysts polled by Capital IQ expected $1.70.

Revenue for the quarter ended Sept. 30 was $1.26 billion, up from $1.24 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.26 billion.

The company said it expects fiscal Q1 non-GAAP diluted EPS between $1.61 and $1.67 and revenue between $1.10 billion and $1.14 billion.

Four analysts polled by Capital IQ expect normalized EPS of $1.70, and three analysts expect revenue of $1.28 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson's Janssen-Cilag Says EU Approves Indication Extension for Multiple Myeloma Treatment
Johnson & Johnson's Janssen-Cilag Says EU Approves Indication Extension for Multiple Myeloma Treatment
Oct 23, 2024
07:04 AM EDT, 10/23/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) company Janssen-Cilag International said Wednesday that the European Commission (EC) has approved an indication extension for its subcutaneous Darzalex formulation in combination with bortezomib, lenalidomide, and dexamethasone for patients with newly diagnosed multiple myeloma who are eligible for an autologous stem cell transplant. The drug, also known...
CME Group profit rises on trading strength
CME Group profit rises on trading strength
Oct 23, 2024
Oct 23 (Reuters) - CME Group ( CME ) reported a rise in third-quarter profit on Wednesday, as uncertainty around the U.S. monetary policy path led investors to rejig their portfolio, bolstering trading volumes for the derivatives exchange. Net income attributable to common shareholders of CME Group ( CME ) rose to $901.3 million, or $2.50 per share, in the...
Wabtec raises annual profit forecast on strong freight and transit demand
Wabtec raises annual profit forecast on strong freight and transit demand
Oct 23, 2024
Oct 23 (Reuters) - Heavy industrial parts maker Wabtec raised its full-year profit forecast on Wednesday, amid strong demand for its freight and transit products. The Pittsburgh, Pennsylvania-based company is a provider of equipment, systems and aftermarket services for freight and transit rail industries. Wabtec now expects full-year adjusted profit in the range of $7.45 per share to $7.65 per...
Beyond Fires Chief Product Officer as Layoffs Take Effect
Beyond Fires Chief Product Officer as Layoffs Take Effect
Oct 23, 2024
07:03 AM EDT, 10/23/2024 (MT Newswires) -- Beyond (BYON) said Tuesday it terminated former Chief Product Officer Carlisha Robinson without cause, effective immediately, as part of its broader staff cuts. Beyond said the staff reduction plan was approved over the weekend, affecting approximately 20% of its workforce. The layoffs are expected to be substantially implemented by Q4. The move is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved